Tsutomu Takashima

Environmental Science · Physical Sciences

53h-index11.0kcitations683works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Atmospheric aerosols and clouds(90), Breast Cancer Treatment Studies(86), Cancer Treatment and Pharmacology(72), HER2/EGFR in Cancer Research(67), Liver Disease Diagnosis and Treatment(48)

Publications683 total

Axillary surgery in patients with breast cancer with one to three positive micro- or macrometastases in the sentinel lymph nodes: an observational study
Breast Cancer·2025· 2 citedOpen Access
[A Case of Pulmonary Tuberculosis Developed During Neoadjuvant Chemotherapy for HER2-Enriched Breast Cancer].
PubMed·2025
Tasurgratinib in patients with cholangiocarcinoma or gastric cancer: Expansion part of the first‐in‐human phase I study
Cancer Science·2024· 4 citedOpen Access
[The Long Term Result of Rhomboid Flap Reconstruction for Locally Advanced Breast Cancer].
PubMed·2023
Association of Genetic Polymorphism with Taxane-induced Peripheral Neuropathy: Sub-analysis of a Randomized Phase II Study to Determine the Optimal Dose of 3-week Cycle Nab-Paclitaxel in Metastatic Breast Cancer Patients.
PubMed·2022· 1 cited
Adjuvant trastuzumab without chemotherapy for treating early HER2-positive breast cancer in older patients: A propensity score-adjusted analysis of a prospective cohort study
The Breast·2022· 9 citedOpen Access
The Cyclin-Dependent Kinase 4/6 Inhibitor Abemaciclib Is Tolerated Better than Palbociclib by Advanced Breast Cancer Patients with High Serum Albumin Levels
Biological and Pharmaceutical Bulletin·2022· 6 citedOpen Access
Adjuvant trastuzumab without chemotherapy for treating early HER2-positive breast cancer in older patients: a propensity score-adjusted analysis of a prospective cohort study
Research Square (Research Square)·2022· 1 citedOpen Access
Observational study of axilla treatment for breast cancer patients with 1 to 3 positive micrometastases or macrometastases in sentinel lymph nodes.
Journal of Clinical Oncology·2022
The relationship between high absolute lymphocyte counts and favorable prognosis in eribulin therapy is seen in first-line chemotherapy for metastatic breast cancer: Combined analysis of two phase 2 studies
2022Open Access
Development and validation of a deep learning model for detection of breast cancers in mammography from multi-institutional datasets
PLoS ONE·2022· 29 citedOpen Access
Abstract P4-05-06: High absolute lymphocyte counts are associated with longer overall survival in patients with metastatic breast cancer treated with eribulin as the first-line chemotherpy. Combined analysis of two phase 2 study
Cancer Research·2022
Abstract P4-01-15: Eribulin treatment for hormone receptor positive breast cancer cells with resistant to endocrine therapy promotes re-expression of estrogen receptor
Cancer Research·2022
The Relationship between High Absolute Lymphocyte Counts and Favorable Prognosis in Eribulin Therapy is seen in First-Line Chemotherapy for Metastatic Breast Cancer: Combined Analysis of Two Phase 2 Studies
Journal of Pharmacy and Pharmacology Research·2022Open Access
[A Case of Liver Abscess during Treatment for Abemaciclib-Induced Interstitial Lung Disease].
PubMed·2022· 1 cited
[A Case of Adenoid Cystic Carcinoma of the Breast].
PubMed·2021
[Experience with BD EleVationTM in Vacuum-Assisted Biopsy].
PubMed·2021
An Exploratory Phase II Study of Eribulin Re-challenge After Short Term Therapy of 5-Fluorouracil for HER2 Negative, Advanced or Recurrent Breast Cancer
Anticancer Research·2021· 1 citedOpen Access
Correction to: Quality of life in a randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer
Breast Cancer·2021· 1 citedOpen Access
Quality of life in a randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer
Breast Cancer·2021· 3 citedOpen Access
page 1 of 35Next →

Frequent Co-authors

Osamu Matsui(21), Jun Yoshikawa(17), Kosei Hirakawa(16), M Kadoya(13), Toshifumi Gabata(13), Shinichiro Kashiwagi(13), Yuka Asano(11), Masahiko Ohsawa(10), Naoyoshi Onoda(8), Satoru Noda(8), Wataru Goto(8), Masaichi Ohira(7), Y Kawamori(6), Koji Takada(6), Yasuni Nakanuma(5), K. Uéda(5), Akitaka Nonomura(5), Masumi Kadoya(5), Masayuki Suzuki(5), Katsuyuki Takahashi(5)